VLE Therapeutics
Gerard Barrett has held various finance and structuring roles in organizations such as VLE Therapeutics, Santander Corporate & Investment Banking, and RockArmour Capital Partners. With a background in engineering and experience in restructuring distressed loans and developing structured finance solutions, Gerard brings a wealth of expertise to his current role as Head of Finance at VLE Therapeutics, where he is leading the creation of the Factory of the Future for Advanced Biotherapeutic and Vaccine Manufacturing. Gerard's career has been marked by a focus on innovation and strategic financial management.
This person is not in any teams
This person is not in any offices
VLE Therapeutics
Vaccines, CGTs, and other advanced therapeutics are taking too long to reach patients. Scientists want to move faster, but external manufacturers prioritize ‘contracts’ over the need for innovation and speed in GMP manufacturing. The promise of patient-focused partnerships remains out of reach until now. *Speed through Science* VLE is led by the brightest scientific minds and powered by iACHIEVE© and BioACHIEVE© our digital and process science platforms. For every medicine, we redefine CMC, tech transfer, and GMP operations through digitization and scientific excellence creating a new frontier for medicine acceleration and a new state-of-the-art for GMP manufacturing. *Patient-Focused Partnerships* We constantly strive to understand the unique clinical and CMC landscape of every medicine we work on, enabling us to deliver the manufacturing breakthroughs our partners need to achieve audacious supply chain goals that truly serve patients. *Digital First GMP* Our expertise in manufacturing science and GMP operations is accentuated by our first-in-class digital strategy – iACHIEVE©. By digitizing our process, analytical and manufacturing science breakthroughs we can deliver medicines with the speed that patients deserve and the precision regulators demand.